An all-in-one nanoparticle for overcoming drug resistance: doxorubicin and elacridar co-loaded folate receptor targeted PLGA/MSN hybrid nanoparticles.

Tonbul H., Şahin A., Öztürk S. C., Ultav G., Tavukçuoğlu E., Akbaş S., ...More

Journal of drug targeting, vol.32, pp.1101-1110, 2024 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 32
  • Publication Date: 2024
  • Doi Number: 10.1080/1061186x.2024.2374034
  • Journal Name: Journal of drug targeting
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, BIOSIS, Chemical Abstracts Core, International Pharmaceutical Abstracts, MEDLINE
  • Page Numbers: pp.1101-1110
  • Hacettepe University Affiliated: Yes